Analyst	Recommendation	Action	Price target	Projected	Date
Leonardo Olmos UBS	Hold	Initiated	$9.00	+12.6%	09/03/2026
Michael Rollins Citi	Hold	Maintained	$9.00	+12.6%	08/13/2026
Andres Coello Scotiabank	Hold	Maintained	$5.40	-32.4%	06/18/2026

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	1.11B	1.16B	1.08B	1.10B
Cost of goods sold	247.60M	263.30M	235.50M	229.00M
Cost of revenue	247.60M	263.30M	235.50M	229.00M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	36.60M	44.40M	40.40M	41.80M
Operating expense	659.90M	1.20B	694.70M	681.10M
Total operating expenses	907.50M	1.46B	930.20M	910.10M
Operating income	205.00M	-302.10M	152.60M	192.50M
Other non operating income	-2.20M	-5.00M	-14.10M	-24.20M
EBT including unusual items	11.80M	23.80M	10.50M	24.00M
EBT excluding unusual items	29.30M	-403.90M	20.20M	35.30M
Income tax expense	-4.10M	52.20M	26.70M	34.60M
Effective tax rate	-34.75%	219.33%	254.29%	144.17%
Other operating expenses	394.70M	896.20M	405.60M	400.40M
Net income	3.30M	-54.80M	-22.70M	-24.00M
Net profit margin	0.30%	-4.73%	-2.10%	-2.18%
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-164.70M	-100.10M	-164.20M	-142.10M
Net interest expenses	-164.70M	-100.10M	-164.20M	-142.10M
Depreciation and amortization charges	213.60M	245.00M	217.10M	226.10M
EBITDA	418.60M	-57.10M	369.70M	418.60M
Gain or loss from assets sale	-	-	-	-

Ask anything